Sulfamethoxazole and Trimethoprim Injection Multiple-Dose Vial 30 mL (RX)

Powerful IV Antibiotic for Bacterial Infections & Sepsis

Sulfamethoxazole and Trimethoprim Injection Multiple-Dose Vial 30 mL by Somerset Therapeutics delivers fast-acting, hospital-grade broad-spectrum infection treatment for both adults and pediatric patients. As a potent IV antibiotic combination—also known as Co-Trimoxazole or IV Bactrim—this clinician-trusted solution effectively treats serious urinary tract infections (UTIs), respiratory tract infections, Pneumocystis jirovecii pneumonia (PCP), sepsis, skin and soft tissue infections, and more. The 30 mL multiple-dose vial offers flexible dosing and proven efficacy against a wide array of susceptible bacteria, making it an essential for hospitals, ICUs, and infection control programs.

Uses and Indications

Sulfamethoxazole and Trimethoprim Injection is indicated for:

• Serious urinary tract infections (UTIs) requiring IV therapy
• Respiratory tract infections (bronchitis, pneumonia, particularly PCP in immunosuppressed patients)
• Pneumocystis jirovecii pneumonia (PCP)—prophylaxis and treatment in HIV/AIDS, transplant, or immunocompromised individuals
• Sepsis and bacteremia
• Shigellosis and other severe GI tract infections
• Skin and soft tissue infections
• Alternative treatment for patients unable to take oral antibiotics

Not indicated for viral infections. Use only under physician direction.

Key Benefits

• Broad-Spectrum Antibacterial Power: Combines two powerful agents (sulfamethoxazole + trimethoprim) for superior coverage against Gram-positive and Gram-negative pathogens.
• IV Administration for Serious Infections: Rapid and reliable therapy for severe infections where oral antibiotics are inadequate.
• Flexible Dosing: 30 mL multiple-dose vial allows for individualized dosing in adults and pediatric patients.
• Trusted for PCP Prophylaxis and Treatment: Go-to first-line therapy for Pneumocystis jirovecii (carinii) pneumonia in immunocompromised patients.
• Clinician’s Choice: Efficacy proven in complex and hospital-acquired infections—often used in ICU, surgical, and transplant patients.
• FDA-Approved Quality: Manufactured to strict quality standards by Somerset Therapeutics.

Product Details

• Brand: Somerset Therapeutics
• Active Ingredients: Sulfamethoxazole and Trimethoprim
• Strength: (typically 80 mg/mL sulfamethoxazole + 16 mg/mL trimethoprim per mL – verify per product insert)
• Volume: 30 mL multiple-dose vial
• NDC: 70069-0363-01
• Route: Intravenous (IV) infusion only
• Form: Sterile solution for injection

How It Works

This combination antibiotic inhibits two consecutive steps in bacterial folate synthesis, maximizing bacterial kill and reducing the risk of resistance. Its dual mechanism makes it highly effective for a variety of complicated and resistant infections.

Who Should Use This Product?

• Emergency rooms, ICUs, and hospital inpatient settings treating life-threatening bacterial infections
• Transplant teams and infectious disease specialists needing PCP prophylaxis/treatment for immunocompromised patients
• Clinicians managing UTI, sepsis, or pneumonia where oral route is not possible
• Pediatric or adult patients requiring IV therapy as prescribed by a healthcare professional

Not for:

• Patients with allergy to sulfa drugs or trimethoprim
• Individuals with severe liver/kidney disease without specialist oversight
• Patients with history of blood disorders related to folate deficiency

Possible Side Effects

• Nausea, vomiting, or loss of appetite
• Rash or skin reactions
• Increase in potassium levels
• Kidney function changes
• Anemia, leukopenia, or thrombocytopenia (rare)
• Phlebitis at site of infusion

Serious Side Effects (Seek Immediate Medical Help):

• Severe allergic reaction (anaphylaxis)
• Stevens-Johnson syndrome or toxic epidermal necrolysis
• Severe or persistent diarrhea (C. difficile–associated)
• Blood disorders or renal impairment

Important Safety & Drug Interaction Information

• Drug Interactions: May interact with warfarin, ACE inhibitors, methotrexate, diuretics, and other drugs affecting kidney or blood function.
• Monitoring: Regular blood counts and kidney/liver function tests recommended during therapy.
• Use in Pregnancy: Not advised unless clearly needed—consult infectious disease specialist.

FAQs

How is it administered? By slow intravenous infusion, typically over 60–90 minutes, in a hospital or clinical setting.

Why use multiple-dose vials? Allows for repeated, accurate dosing for multi-day, multi-patient use in busy hospital environments.

Is this the same as Bactrim IV? Yes, it is the generic equivalent and often referred to in clinical guidelines as IV Bactrim or co-trimoxazole injection.

Order Sulfamethoxazole and Trimethoprim Injection Multiple-Dose Vial 30 mL by Somerset Therapeutics Now!

For serious, hospital-acquired, and resistant infections, trust Sulfamethoxazole and Trimethoprim Injection 30 mL by Somerset Therapeutics. Order today for reliable, broad-spectrum infection control and consistent hospital supply—backed by clinical excellence and FDA approval.